More than 85% of HCC cases worldwide retain markers for HBV and HCV, indicating that HBV and HCV are major etiological agents for HCC. In addition to causing chronic inflammation and cell death-regeneration cycles, HBV and HCV encode oncogenic proteins. For example, HBx of HBV and p21core of HCV are oncogenic in transgenic mice, suggesting that these proteins may play a direct role in hepatitis-mediated hepatocarcinogenesis. Because viruses have been invaluable tools for discovering key pathways for human carcinogenesis, our initial study was focusing on the molecular aspect of HBx, a viral oncoprotein encoded by hepatitis B virus. We discovered that HBx contains a functional nuclear export signal motif that utilizes the Ran/Crm1 complex, a component essential in nucleocytoplasmic transport of many cellular proteins. Interestingly, this viral protein not only uses, but also disrupts Ran/Crm1-dependent activities, presumably to prevent a host antiviral response. This finding implicates the Ran/Crm1 complex in the molecular pathogenesis of HBV. Such an approach also allows us to uncover a novel role of the Ran/Crm1 complex in regulating cellular proteins that control centrosome duplication and mitotic spindle assembly, in addition to its role in nucleocytoplasmic transport. Recently, we have revealed nucleophosmin as a novel substrate for Ran/Crm1 to negatively regulate unnecessary centrosome duplication. In addition, we demonstrated a HBV/HBx-dependent activation of RanBP1, a Ran-binding protein that is known to destabilize the Ran/Crm1 complex. Elevated RanBP1 is also observed in HBV-positive liver tissues and in HCC. Increased expression of RanBP1 leads to multipolar spindles and abnormal mitoses. Thus, the combined effects of HBV/HBx contribute to chromosome instability. These findings led us to generate a new hypothesis in which the Ran/Crm1 complex serves as the centrosome duplication checkpoint by providing a 'loading dock' mechanism that controls cellular homeostasis, and the disruption of this complex may result in genomic instability, which may be an early step in viral hepatitis-mediated hepatocarcinogenesis. Currently, we are exploring other potential partners associated with this complex that may regulate spindle assembly.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005793-11
Application #
7289926
Study Section
(LHC)
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
2005
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Zhao, Xuelian; Ji, Junfang; Yu, Li-Rong et al. (2015) Cell cycle-dependent phosphorylation of nucleophosmin and its potential regulation by peptidyl-prolyl cis/trans isomerase. J Mol Biochem 4:95-103
Ji, Junfang; Wang, Xin Wei (2010) A Yin-Yang balancing act of the lin28/let-7 link in tumorigenesis. J Hepatol :
Budhu, A; Chen, Y; Kim, J W et al. (2007) Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. Carcinogenesis 28:1552-60
Lim, Mi Jung; Wang, Xin Wei (2006) Nucleophosmin and human cancer. Cancer Detect Prev 30:481-90
Budhu, Anuradha S; Wang, Xin W (2005) Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1. Cell Cycle 4:1510-4
Zhang, Yuexing; Wang, Xin-Wei; Jelovac, Danijela et al. (2005) The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci U S A 102:9890-5
Wang, Wei; Budhu, Anuradha; Forgues, Marshonna et al. (2005) Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol 7:823-30
Forgues, Marshonna; Difilippantonio, Michael J; Linke, Steven P et al. (2003) Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol Cell Biol 23:5282-92
Staib, Frank; Hussain, S Perwez; Hofseth, Lorne J et al. (2003) TP53 and liver carcinogenesis. Hum Mutat 21:201-16
Linke, Steven P; Sengupta, Sagar; Khabie, Nissim et al. (2003) p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res 63:2596-605